Genetic modification of αGal expression in xenogeneic endothelial cells yields a complex immunological response

Tissue Engineering

Volumn 7, Issue 6, 2001, Pages 743-756

  Fischbeck, Julie A ^a   Baier, Jennie M ^a   Akella, Rama ^b   Hern Anderson, Diane ^b   Schmidt, Christine E ^a,c  

^a The University of Texas at Austin   (United States)

^b Sulzer Biologics   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARBOHYDRATE DERIVATIVE; DISACCHARIDE; EPITOPE; GALACTOSE ALPHA (1-3) GALACTOSE; UNCLASSIFIED DRUG; GALACTOSYLTRANSFERASE; N ACETYLLACTOSAMINIDE ALPHA 1,3 GALACTOSYLTRANSFERASE; N-ACETYLLACTOSAMINIDE ALPHA-1,3-GALACTOSYLTRANSFERASE;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CATTLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOLYSIS; DNA MODIFICATION; ENDOTHELIUM CELL; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY; XENOGRAFT; ANIMAL; CELL LINE; CYTOLOGY; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; NEWBORN; TISSUE ENGINEERING; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

ANIMAL; CELL LINE; ENDOTHELIUM, VASCULAR; GALACTOSYLTRANSFERASES; GRAFT REJECTION; HUMAN; INFANT, NEWBORN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE ENGINEERING; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035542959     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632701753337690     Document Type: Article

References (48)

1. Xenografts-future prospects for clinical transplantation
2. New directions for organ transplantation
3. Discordant xenografting: Challenges and controversies
4. The immunological barrier to xenotransplantation
5. Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cells
6. Delayed xenograft rejection
7. Delayed xenograft rejection
8. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection
9. Direct activation of porcine endothelial cells by human natural killer cells
10. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-I expression
11. Natural killer cell-endothelial cell interactions in xenotransplantation
12. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation
13. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies
14. Two genetic approaches to the galactose alpha-(1, 3) galactose xenoantigen
15. Characterization of an alpha-1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene
16. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:alpha-D-Gal(1, 4)-D-GlcNAc alpha(1, 3)-galactosyltransferase cDNA
17. The blood group-specific human glycosyltransferases
18. A unique natural human IgG antibody with anti-α-galactosyl specificity
19. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora
20. Xenotransplantation: The importance of the Galalpha 1, 3 Gal epitope in hyperacute vascular rejection
21. Effects of leflunomide and deoxyspergualin in the guinea pig-rat cardiac model of delayed xenograft rejection
22. Role of cell surface carbohydrate moieties in monocytic cell adhesion to endothelium in vitro
23. Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by α1, 3 galactosyltransferase gene transfection
24. Reduction of metastatic properties of BL6 melanoma cells expressing terminal fucose α1-2-galactose after α1, 2-fucosyltransferase cDNA transfection
25. Increase of rat colon carcinoma cells tumorigenicity by α(1-2)fucosyltransferase gene transfection
26. Changes in cell surface glycosylation in alpha-1, 3-galactosyltransferase knockout and alpha-1, 2-fucosyltransferase transgenic mice
27. High-level porcine endothelial cell expression of alpha-(1, 2)-fucosyltransferase reduces human monocyte adhesion and activation
28. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: Relevance to discordant xenografting in man
29. The alpha-1, 3-galactosyltransferase knockout mouse
30. Down-regulation of gal-alpha-(1, 3)-Gal expression by alpha-1, 2-fucosyltransferase
31. Reduction in the level of Gal(alpha-1, 3)Gal in transgenic mice and pigs by the expression of an alpha(1, 2)fucosyltransferase
32. Reduction in gal-alpha 1, 3-Gal epitope expression in transgenic mice expressing human H-transferase
33. Characterization of pigs transgenic for human decay-accelerating factor
34. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection
35. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement mediated damage
36. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis
37. Switching amino-terminal cytoplasmic domains of alpha(1, 2)fucosyltransferase and alpha(1, 3)galactosyltransferase alters the expression of H substance and gal-alpha(1, 3)gal
38. Antisense inhibition of pig α1, 3galactosyl-transferase leads to a reduction in expression of the major target for human natural antibodies on pig vascular endothelial cells
39. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection
40. Bovine alpha 1-3-galactosyltransferase: Isolation and characterization of a cDNA clone. Identification of homologous sequences in human genomic DNA
41. Transformation of mammalian cells with genes from procaryotes and eucaryotes
42. Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA
43. Transfection of human endothelial cells
44. Characterization of the substrate specificity of alpha-1, 3-galactosyltransferase utilizing modified N-acetyllactosamine disaccharides
45. Effects of inflammatory cytokines and phorbol esters on the adhesion of U937 cells, a human monocyte-like cell line, to endothelial cell monolayers and extracellular matrix proteins
46. Transcriptional and posttranscriptional regulation of alpha-1, 3-galactosyltransferase in activated endothelial cells results in decreased expression of Gal alpha-1, 3-Gal
47. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells